FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Hikma Pharmaceuticals methylPREDNISolone Sodium Succinate For Recall

methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by:…

Hikma Pharmaceuticals USA Inc. · Cherry Hill, NJ

Risk level
Class III
Reported by FDA
Jan 29, 2020
Recall ID
D-0801-2020
Check your lot numberHow we source this data

Summary

Hikma Pharmaceuticals recalled methylPREDNISolone Sodium Succinate For starting Jan 14, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0801-2020 on Jan 29, 2020. Reason: Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol. Status: Terminated.

Why it was recalled

Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.

Product description

methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by: HIKMA FARMACEUTICA (PORTUGAL), SA; Dist by: WEST-WARD, Eatontown, NJ 07724, NDC 0143-9850-01.

Lot numbers, UPCs & expiration codes

Lot #: 1901113.1, Exp JUL 2021

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0801-2020
Classification
Class III
Status
Terminated
Recall initiated
Jan 14, 2020
FDA report date
Jan 29, 2020
Quantity
4840 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hikma Pharmaceuticals USA Inc.

Original FDA data

Every field from FDA enforcement report D-0801-2020, exactly as published.

Show all FDA fields
City
Cherry Hill
State
NJ
Status
Terminated
Country
United States
Event ID
84676
Address
2 Esterbrook Ln
Code information
Lot #: 1901113.1, Exp JUL 2021
Postal code
08003-4002
Report date
Jan 29, 2020
Product type
Drugs
Recall number
D-0801-2020
Classification
Class III
Recalling firm
Hikma Pharmaceuticals USA Inc.
Product quantity
4840 vials
Termination date
Sep 8, 2021
Reason for recall
Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.
Voluntary / mandated
Voluntary: Firm initiated
Product description
methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by: HIKMA FARMACEUTICA (PORTUGAL), SA; Dist by: WEST-WARD, Eatontown, NJ 07724, NDC 0143-9850-01.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 14, 2020
Initial firm notification
Letter
Center classification date
Jan 23, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0801-2020, published Jan 29, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls